Athersys Awarded $3.6 Million in Grant Funding For Stem Cell Product Development: http://t.co/bkQAMsRf
posted 2 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Ablynx [Euronext Brussels: ABLX] issued the following statement today. On Friday January 20th at 16.30 C.E.T., De Tijd, a Belgian newspaper, published online what was alleged to be a summary of a full article relating to Ablynx, scheduled to appear in print on Saturday January.21st. The online summary contained a number of negative statements and quotations apparently resulting from an interview with Dr Edwin Moses, Chairman and CEO of Ablynx. These statements and quotations were poorly translated or simply not reflective of the interview that took place. Ablynx's stock price fell almost 14% in about an hour and over 400,000 shares were traded in total - two to three times the normal volume. A number of investors that contacted Ablynx directly were clearly completely misled by the summary article and assumed that disappointing news had been announced. In fact, no material new information had been provided during the interview with De Tijd. read more
Galapagos NV (Euronext: GLPG) announced today a capital increase arising from employee warrant exercises. read more
